Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -8.05M
March 31, 2026 -73.50M
December 31, 2025 -36.79M
September 30, 2025 -119.84M
June 30, 2025 44.16M
March 31, 2025 -105.62M
December 31, 2024 -39.25M
September 30, 2024 48.66M
June 30, 2024 -97.08M
March 31, 2024 -101.38M
December 31, 2023 -40.27M
September 30, 2023 -52.98M
Date Value
June 30, 2023 -54.82M
March 31, 2023 -66.26M
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021 -63.76M
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020 -44.99M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Personalis, Inc. -25.77M
10X Genomics, Inc. 16.97M
Twist Bioscience Corp. 1.115M
Moderna, Inc. -526.00M
IQVIA Holdings, Inc. 558.00M